Search Results

MEDICINOVA INITIATES PHASE II TRIAL FOR MN-221.

Subjects: *LICENSES; DRUG development; DRUG efficacyMEDICINOVA Inc. ; KISSEI Pharmaceutical Co. Ltd.

• Source: Biotech Business. Feb2007, Vol. 20 Issue 2, p1-2. 2p.

Record details

OXIGENE GETS POSITIVE RESULTS OF PHASE II STUDY OF CA4P.

Subjects: DRUG efficacy; INTRAVENOUS therapy; STATINS (Cardiovascular agents)MATEON Therapeutics Inc. MATEON Therapeutics Inc. MATEON Therapeutics Inc. OXGN

• Source: Biotech Business. Feb2007, Vol. 20 Issue 2, p2-3. 2p.

Record details

FDA ACCEPTS APPLICATION FOR XOLAIR PREFILLED SYRINGE.

Subjects: SYRINGESUNITED States. Food & Drug Administration

• Source: Biotech Business. Sep2020, Vol. 33 Issue 9, p5-6. 2p.

Record details

Clinical Considerations for Billing Observation Services.

• Authors : Smith, Jeff A.

Subjects: *MEDICARE; HOSPITAL outpatient prospective payment; MEDICAL recordsUNITED States

• Source: Health Care Biller. Apr2002, Vol. 11 Issue 2, p1. 3p.

Record details

MEDICINOVA REPORTS POSITIVE RESULTS FOR PHASE I OF MN-029.

Subjects: CLINICAL trials; CLINICAL medicine research; MEDICAL experimentation on humansMEDICINOVA Inc.

• Source: Worldwide Biotech. Nov2007, Vol. 19 Issue 11, p1-2. 2p.

Record details

Current trends in asthma therapy.

• Authors : Shaw, Kendall

Subjects: *CONTINUING education; ASTHMA treatment; PHARMACYUNITED States

• Source: Drug Store News. 6/22/98, Vol. 20 Issue 9, pCP44. 5p. 1 Diagram, 4 Charts.

Record details

Online management comes of age for chronic conditions.

• Authors : Kaufman, Neal^1,2

Subjects: *ONLINE information services; *MEDICAL care; PHYSICIAN-patient relationsUNITED States

• Source: Managed Healthcare Executive. Oct2009, Vol. 19 Issue 10, p24-24. 2/3p.

Record details

Overcoming healthcare hurdles.

• Authors : Siegfried, Elaine

Subjects: DERMATOLOGY; PATIENT aftercare; EVALUATION of medical care

• Source: Dermatology Times. Aug2011, Vol. 32 Issue 8, p3-6. 2p.

Record details